Intellectual property, pharmaceuticals and public health: access to drugs in developing countries
Shadlen, K. C., Guennif, S., Guzmán, A. & Lalitha, N.
(Eds.)
(2011).
Intellectual property, pharmaceuticals and public health: access to drugs in developing countries.
Edward Elgar.
This impressive collection offers fascinating new perspectives on the impact of pharmaceutical patents on access to medicines in developing countries. The volume’s editors have put together an important book that sets out clearly the challenges to public health in a wide range of national contexts. The book will be a valuable text for all scholars and decision-makers interested in the global politics of intellectual property rights and public health.
| Item Type | Book |
|---|---|
| Copyright holders | © 2011 The authors |
| Departments | LSE > Academic Departments > International Development |
| Date Deposited | 19 Dec 2011 |
| URI | https://researchonline.lse.ac.uk/id/eprint/40775 |
Explore Further
- RA0421 Public health. Hygiene. Preventive Medicine
- RS Pharmacy and materia medica
- T201 Patents. Trademarks
- http://www.lse.ac.uk/international-development/people/ken-shadlen.aspx (Author)
- http://www.e-elgar.com/bookentry_main.lasso?id=13876 (Publisher)
- https://www.scopus.com/pages/publications/84875362496 (Scopus publication)
- http://www.e-elgar.com/ (Official URL)